10Elms LLP’s Thermo Fisher Scientific TMO Stock Holding History

10Elms LLP’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-34	Closed	-$17.7K	–	531
2024 Q4	$17.7K	Buy	+34	New	+$18.7K	0.02%	360

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

10Elms LLP's TMO Position: Q1 2025 in Review

10Elms LLP sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 34 shares — an estimated $17.7K sold.

10Elms LLP first reported a position in TMO in Q4 2024 and held it in 1 quarter. The position peaked at $17.7K in Q4 2024. 2,570 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

10Elms LLP reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
10Elms LLP sold 34 Thermo Fisher Scientific shares in Q1 2025, an estimated $17.7K.
10Elms LLP first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 1 quarter.
10Elms LLP's Thermo Fisher Scientific position peaked at $17.7K in Q4 2024.
2,570 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on 10Elms LLP's 13F filing for Q1 2025, filed 13 May 2025.